Metabolic & Lysosomal
Also called Wilson's disease, hepatolenticular degeneration
Wilson disease is a rare genetic disorder affecting copper metabolism, caused by mutations in the ATP7B gene that encodes a copper-transporting protein. In normal physiology, excess copper is excreted through bile, but in Wilson disease, copper accumulates progressively in the liver, central nervous system, and other organs, causing severe damage if untreated.
About trials for Wilson Disease
Clinical trials for Wilson disease are evaluating new copper-chelating agents, zinc formulations, and gene therapy approaches. The Wilson Disease Association maintains a registry and provides current trial information and connects patients with specialists experienced in Wilson disease management.
Try Match Me →Usually manifests in childhood or young adults (ages 6-45). Affects males and females equally. Has higher prevalence in certain ethnic populations including Ashkenazi Jews, Southern Europeans, and East Asians.
Clinical trials for Wilson disease are evaluating new copper-chelating agents, zinc formulations, and gene therapy approaches. The Wilson Disease Association maintains a registry and provides current trial information and connects patients with specialists experienced in Wilson disease management. Check ClinicalTrials.gov for ongoing studies in your region. Because early diagnosis and treatment are so critical, if you have a family member with Wilson disease, genetic testing and screening should be discussed even before symptoms develop. Genetic counselors and hepatologists specializing in metabolic liver disease can help determine trial eligibility.
Phenylketonuria is an inherited metabolic disorder caused by a missing enzyme that prevents the body from properly break...
Fabry disease is a rare inherited lysosomal storage disorder where a missing enzyme causes fatty substances called globo...
Pompe disease is a rare inherited lysosomal storage disorder caused by deficiency of the enzyme acid alpha-glucosidase, ...